Extract of Holding Statement of Stakeholders Empowerment
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI Trading As ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP
Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SANJEEVAK 1586083 01/08/2007 MANOJ ANANT JOSHI trading as ;AKSHAY PHARMA REMEDIES KAVRANA HOUSE, OPP. COTTON GREEN RLY. STN. MUMBAI-400033. MANUFACTURE & MERCHANT INDIAN NATIONAL Used Since :31/01/2001 MUMBAI MEDICINAL PREPARATIONS. 537 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 SEPTIGARD 1741718 08/10/2008 INDERJIT SINGH trading as ;INDERJIT SINGH B-104 , SWASTHYA SINGH , NEW DELHI -92 MERCHANTS & MANUFACTUERERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Proposed to be Used DELHI MEDICINAL & PHARMACEUTICAL PREPARATIONS. 538 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 FAIR & BEAUTY 1803779 08/04/2009 GALPHA LABORATORIES LIMITED 221, Kanakia Zillion, E Wing Bandra Kurla Complex Annex LBS Marg & CST Road Junction Kurla West MUMBAI 400070 MANUFACTURERS AND MERCHANTS INDIAN NATIONAL Used Since :15/11/2007 MUMBAI PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND SUBSTANCES 539 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 O-BAMA 1815900 08/05/2009 KREMOINT PHARMA PVT. LTD. 151/5, SHRI KRISHNA DARSHAN, GARODIA NAGAR, GHATKOPAR (E), BOMBAY-400 077. MANUFACTURERS AND MERCHANTS. A CORPORATE ENTITY INCORPORATED IN INDIA UNDER THE COMPANIES ACT 1956. Address for service in India/Attorney address: KRISLAW CONSULTANTS BUILDING NO.4, C/104, SHANKESHWAR PALMS, BEHIND MODEL SCHOOL, KUMBHARKHANPADA, SUBHASH ROAD, DOMBIVILI(W) 421202 Used Since :02/05/2009 MUMBAI PHARMACETICAL AND MEDICINAL PREPARATIONS. 540 Trade Marks Journal No: 1836 , 12/02/2018 Class 5 AYUSHAKTI D-VYRO 1815928 08/05/2009 SMITA NARAM BUNGALOW NO.31, NEXT TO M. -
Ador Welding Limited Regd
ADOR WELDING LIMITED REGD. & CORPORATE OFFICE Ador House, 6, K. Dubash Marg, Fort, Mumbai - 400 001-16 Maharashtra - India G.P.O. Box No. 1546 Phone : (022) 2284 2525 / 6623 9300 Fax : (022) 2287 3083 / 2283 0393 Website : www.adorwelding.com Email : [email protected] CIN. : L70100MH1951PLC008647 AWL/SEC/SE/2020-21 29 th August, 2020 BSE LTD. NATIONAL STOCK EXCHANGE OF INDIA LTD. Phiroze Jeejeebhoy Towers, Exchange Plaza, C - 1, Block G, 01 st Floor, Dalal Street, Bandra-Kurla Complex, Fort, Bandra (East), Mumbai - 400 023. Mumbai - 400 051. Company Scrip Code: 517041 Company Scrip Code: ADORWELD Dear Sir / Madam, Sub: 67 th Annual Report of Ador Welding Limited for FY 2019-20 In furtherance to our letter dated 23 rd June, 2020 and pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith copy of the 67 th Annual Report of the Company for FY 2019-20. The said Annual Report is also placed on the website of our Company at https://www.adorwelding.com/images/pdf/67th-Annual- Report-for-FY-2019-20.pdf In compliance with the Ministry of Corporate Affairs (MCA) circulars, the 67 th Annual Report for FY 2019-20 is being sent only by electronic mode to those Members, whose e-mail addresses are registered with the Company / Depositories / RTA. We hereby request you to take the above / subject information on record and acknowledge its receipt. Thanking you, Yours Sincerely, For ADOR WELDING LIMITED Sd/- VINAYAK M. BHIDE COMPANY SECRETARY & NODAL OFFICER Encl.: As above C O N T A C T U S ADOR WELDING LIMITED P A S S I O N F O R W E L D I N G S I N C E 1 9 5 1 REGISTERED & CORPORATE OFFICE Ador House, 6, K. -
Ajanta Pharma Limited
AJANTA PHARMA LIMITED CIN : L24230MH1979PLC022059 Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop, Kandivli (West), Mumbai - 400 067, Maharashtra, India Tel.: +91 22 6606 1000, Fax: +91 22 6606 1200 | E-mail: [email protected] | Website: www.ajantapharma.com POST BUYBACK PUBLIC ANNOUNCEMENT FOR THE ATTENTION OF EQUITY SHAREHOLDERS/ BENEFICIAL OWNERS OF EQUITY SHARES OF AJANTA PHARMA LIMITED This public announcement (the “Post Buyback Public Announcement”) is being made pursuant to the provisions of Regulation 24(vi) of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, for the time being in force including any statutory modifications and amendments from time to time (the “Buyback Regulations”). This Post Buyback Public Announcement should be read in conjunction with the Public Announcement dated November 4, 2020 which was published on November 5, 2020 (the “Public Announcement”) and the letter of offer dated November 25, 2020 (the “Letter of Offer”) issued in connection with the Buyback. The terms used but not defined in this Post Buyback Public Announcement shall have the same meanings as assigned in the Public Announcement and the Letter of Offer. 1. THE BUYBACK 1.1 Ajanta Pharma Limited (the “Company”) had announced the Buyback of not exceeding 7,35,000 (Seven Lakh Thirty Five Thousand) fully paid-up equity shares of face value of ₹2 each (“Equity Shares”) from all the existing shareholders / beneficial owners of Equity Shares as on the record date (i.e. Friday, November 13, 2020), on a proportionate basis, through the “Tender Offer” process at a price of ₹1,850/- (Rupees One Thousand Eight Hundred and Fifty Only) per Equity Share payable in cash for an aggregate consideration not exceeding ₹ 135,97,50,000 (Rupees One Hundred Thirty Five Crores Ninety Seven Lakhs and Fifty Thousand only) excluding the Transaction Costs (“Buyback Offer Size”). -
Inner 25 India Pharma & Healthcare Fund
Modera erate tely Mod High to e H w at ig o er h L d o M V e r y w H Tata India Pharma & Healthcare Fund o i L g (An open ended equity scheme investing in Pharma and Healthcare Services Sector) h Riskometer Investors understand that their principal As on 30th June 2021 PORTFOLIO will be at Very High Risk INVESTMENT STYLE Company name No. of Market Value % of Company name No. of Market Value % of Primarily focuses on investment in at least 80% of its net Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India. Equity & Equity Related Total 55184.24 97.88 Glenmark Pharmaceuticals Ltd. 167000 1089.76 1.93 INVESTMENT OBJECTIVE Healthcare Services Sanofi India Ltd. 13000 997.39 1.77 The investment objective of the scheme is to seek long Apollo Hospitals Enterprise Ltd. 70500 2551.99 4.53 Gland Pharma Ltd. 19662 673.29 1.19 term capital appreciation by investing atleast 80% of its Fortis Healthcare Ltd. 795000 1935.03 3.43 Laurus Labs Ltd. 90000 619.79 1.10 net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in Syngene International Ltd. 265000 1545.75 2.74 India.However, there is no assurance or guarantee that the investment objective of the Scheme will be Narayana Hrudayalaya Ltd. 301420 1483.74 2.63 Other Equities^ 1186.14 2.10 achieved.The Scheme does not assure or guarantee any Metropolis Healthcare Ltd. -
MF 35 Fund One Pager
BR“BuyS RightT : BSit TightR” ST BRSnowT Bin fourRS differentTBRS colorsTBRS BRSTBRSTBRSTBR Motilal Oswal MOSt Focused Invests in enduring B25 RFund STBRSTBwRealth creaStors T Motilal Oswal MOSt Focused Invests in emerging BMidcapR 30 Fund TBRwealth creators T BRSTBSRSTBRSTBSRS Motilal Oswal MOSt Focused Invests in emerging and BMulticapRS 35 FundT BRSTBRenduringST wealthB creatorRs Lock in fund that invests Motilal Oswal MOSt Focused in wealth creators BLongR Term SFund TBRSTBplusR Saves TSax T BR TBR T BRSTBSRSTBRSTBSRS Focused Low Churn QGLP No load BRSTBPortfolioRSTBPortfolioRSTStocksBR BRSInvesTt nowB to addR colorSs Tto yourB porRolioST BRSCall:T 1800-200-6626B | SMS:R FOCUSS to 575753T BRSTBRS Website: www.motilaloswalmf.com Our Investment Philosophy The recommended way to create Wealth from equity- 'Buy Right : Sit Tight' At Molal Oswal Asset Management Company (MOAMC), our investment philosophy and invesng style is centered on 'Buy Right: Sit Tight‘ principal. ‘Buy Right' means buying quality companies at a reasonable price and 'Sit Tight' means staying invested in them for a longer me to realise the full growth potenal of the stocks. Buy Right Stock Characteristics Sit Tight Approach QGLP ‘Q’uality denotes quality of the business and Buy and Hold: We are strictly buy and hold management investors and believe that picking the right ‘G’rowth denotes growth in earnings and business needs skill and holding onto these sustained RoE businesses to enable our investors to benefit from the entire growth cycle needs even more ‘L’ongevity denotes longevity of the skill. competitive advantage or economic moat of the business Focus: Our portfolios are high conviction portfolios with 20 to 25 stocks being our ideal ‘P’rice denotes our approach of buying a good n u m b e r. -
List of Approved Vendors for Manufacture & Supply Of
LIST OF APPROVED VENDORS FOR MANUFACTURE & SUPPLY OF M&C ITEMS Index Welding consumables items Clarification to be sought Sr. no Items Category from 1 Manual Metal Arc Welding Electrodes, Class A1 I DD/Weld/M&C 2 Manual Metal Arc Welding Electrodes, Class A2 I DD/Weld/M&C 3 Manual Metal Arc Welding Electrodes, Class A3 I DD/Weld/M&C 4 Manual Metal Arc Welding Electrodes, Class A4 I DD/Weld/M&C 5 Manual Metal Arc Welding Electrodes, Class B1 I DD/Weld/M&C 6 Manual Metal Arc Welding Electrodes, Class B2 I DD/Weld/M&C 7 Manual Metal Arc Welding Electrodes, Class B3 I DD/Weld/M&C 8 Manual Metal Arc Welding Electrodes, Class B4 I DD/Weld/M&C 9 Manual Metal Arc Welding Electrodes, Class C1 I DD/Weld/M&C 10 Manual Metal Arc Welding Electrodes, Class C2 I DD/Weld/M&C 11 Manual Metal Arc Welding Electrodes, Class D I DD/Weld/M&C 12 Manual Metal Arc Welding Electrodes, Class E1 I DD/Weld/M&C 13 Manual Metal Arc Welding Electrodes, Class E2 I DD/Weld/M&C 14 Manual Metal Arc Welding Electrodes, Class F I DD/Weld/M&C 15 Manual Metal Arc Welding Electrodes, Class G I DD/Weld/M&C 16 Manual Metal Arc Welding Electrodes, Class H4A I DD/Weld/M&C 17 Manual Metal Arc Welding Electrodes, Class H4B I DD/Weld/M&C 18 Manual Metal Arc Welding Electrodes, Class K I DD/Weld/M&C 19 Manual Metal Arc Welding Electrodes, Class L I DD/Weld/M&C 20 Manual Metal Arc Welding Electrodes, Class M1 I DD/Weld/M&C 21 Manual Metal Arc Welding Electrodes, Class M2 I DD/Weld/M&C 22 Manual Metal Arc Welding Electrodes, Class M3 I DD/Weld/M&C 23 Manual Metal Arc Welding Electrodes, -
CARE Ratings Ltd
CARE/HO/RL/2020-21/2749 Mr. Arvind Agrawal Chief Financial Officer Ajanta Pharma Limited Ajanta House, Charkop, Kandivali (W), Mumbai-400067 October 1, 2020 Confidential Dear Sir, Credit rating for bank facilities On the basis of recent developments including operational and financial performance of your company for FY20 (audited) and Q1FY21 (provisional), our Rating Committee has reviewed the following ratings: Facilities Amount Rating1 Rating (Rs. crore) Action Long-term/Short-term Bank 55.00 CARE AA; Stable/CARE A1+ Facilities (reduced from 87.50) (Double A; Outlook: Stable/A Reaffirmed One Plus) Total 55.00 (Rs. Fifty Five crore only) 2. Refer Annexure 1 for details of rated facilities. 3. The rationale for the rating will be communicated to you separately. A write-up (press release) on the above rating is proposed to be issued to the press shortly, a draft of which is enclosed for your perusal as Annexure-2. We request you to peruse the annexed document and offer your comments if any. We are doing this as a matter of courtesy to our clients and with a view to ensure that no factual inaccuracies have inadvertently crept in. Kindly revert as early as possible. In any case, if we do not hear from you by October 5, 2020 we will proceed on the basis that you have no any comments to offer. 4. CARE reserves the right to undertake a surveillance/review of the rating from time to time, based on circumstances warranting such review, subject to at least one such review/surveillance every year. 5. -
Statement of Unclaimed Dividend As of 31St March 2017
ADOR WELDING LIMITED CIN: L70100MH1951PLC008647 Nature of Amount: Amount of Unclaimed & Unpaid Dividend NAME ADD1 ADD2 ADD3 ADD4 DPID FOLIO NO. AMOUNT PROPOSED / CLIENT (Rs.) DATE TO ID TRANSFER TO IEPF PUSHPA DHIRAJLAL POOJARA NANI BAZAR DHRANGADHRA 363310 000009 1350.00 04-OCT-2017 M RAMA MOHAN S-1 MADHUVAN APTS MADHU GARDEN VIJAYAWADA 520010 000302 450.00 04-OCT-2017 SUSHILABEN M PATEL 18 SHANTIKUNJ SOC NO 2 GIDC ROAD MANJALPUR VARODARA 390011 000492 1482.00 04-OCT-2017 THE INDIA FUND INC DEUTSCHE BANK AG KODAK HOUSE 22 DR D N ROAD FORT MUMBAI 400001 000511 150.00 04-OCT-2017 SURESH THAVARDAS MEHTA EKTA FASHIONS P O BOX 6239 DUBAI U A E 111111 000590 1350.00 04-OCT-2017 VINOD THAVARDAS MEHTA EKTA FASHIONS P O BOX 6239 DUBAI U A E 111111 000593 1350.00 04-OCT-2017 NITESH KUMAR SHAH A/6 MOON VIHAR FLATS OPP SWASTIK SCHOOL ISHWER BHUVAN ROAD NAVRANGPURA AHMEDABAD 380014 000614 582.00 04-OCT-2017 BISHNU CHAND YADAV C/O P KEDIA & CO. 29-B RABINDRA SARANI 3RD FLOOR R NO 12-E KOLKATA 700073 000795 3000.00 04-OCT-2017 MANORMA MUNDRA C/O SURAJMAL SHOBHACHAND 12 GOVT PLACE EAST 2ND FLR KOLKATA 700069 000881 690.00 04-OCT-2017 MAHESH C BRAHMBHATT 12-A SANGAM CHS LTD S V ROAD SANTACRUZ WEST MUMBAI 400054 000926 900.00 04-OCT-2017 PRIYA RAO TCS LTD ABN AMRO ODC 3RD FL QUADRA II OPP MAGARPATTA CITY HADAPSAR PUNE 411028 001039 1482.00 04-OCT-2017 ANJAL NIRANJAN KARIYA 46 LAKE VIEW EDGEWARE MIDDLESEX HASTRU U K 111111 001051 900.00 04-OCT-2017 MANJU GARG 57 JAYOTI APARTMENTS PARWANA ROAD PITAM PURA DELHI 110034 001069 600.00 04-OCT-2017 ALOKE RANJAN BISWAS SEC VII/ HOUSE NO. -
Company Reliance Industries Limited Tata Consultancy Services
Top 1000 Private Sector Companies (Rank-wise List) Company Reliance Industries Limited Tata Consultancy Services (TCS) Infosys Technologies Ltd Wipro Limited Bharti Tele-Ventures Limited ITC Limited Hindustan Lever Limited ICICI Bank Limited Housing Development Finance Corp. Ltd. TATA Steel Limited Ranbaxy Laboratories Limited HDFC Bank Ltd Tata Motors Limited Larsen & Toubro Limited (L&T) Satyam Computer Services Ltd. Maruti Udyog Limited Bajaj Auto Ltd. HCL Technologies Ltd. Hero Honda Motors Limited Hindalco Industries Ltd Reliance Energy Limited Grasim Industries Limited Jet Airways (India) Ltd. Sun Pharmaceuticals Industries Ltd Cipla Ltd. Gujarat Ambuja Cements Ltd. Videsh Sanchar Nigam Limited The Tata Power Company Limited Sterlite Industries (India) Ltd. Associated Cement Companies Ltd. Nestlé India Ltd. Hindustan Zinc Limited GlaxoSmithKline Pharmaceuticals Limited Siemens India Ltd. Motor Industries Company Limited Mahindra & Mahindra Limited UTI Bank Ltd. Zee Telefilms Limited Bharat Forge Limited ABB Limited i-Flex Solutions Ltd. Dr. Reddy's Laboratories Ltd. Nicholas Piramal India Limited Kotak Mahindra Bank Limited Reliance Capital Ltd. Ultra Tech Cement Ltd. Patni Computer Systems Ltd. Wockhardt Limited Indian Petrochemicals Corporation Limited Biocon India Limited Essar Oil Limited. Asian Paints Ltd. Dabur India Limited Jaiprakash Associates Limited JSW Steel Limited Tata Chemicals Limited Tata Tea Limited Tata Teleservices (Maharashtra) Limited The Indian Hotels Co. Ltd. Glenmark Pharmaceuticals Limited NIRMA Limited Jindal Steel & Power Ltd HCL Infosystems Ltd. Cadila Healthcare Limited Colgate-Palmolive (India) Limited The Great Eastern Shipping Company Limited Aventis Pharma India Ltd Ashok Leyland Limited Pantaloon Retail (India) Limited Indian Rayon And Industries Limited Financial Technologies (India) Ltd United Phosphorus Limited Matrix Laboratories Limited Sesa Goa Limited Lupin Ltd Cummins India Limited Crompton Greaves Limited. -
DEPARTMENT of COMMERCE International
This document is scheduled to be published in the Federal Register on 11/13/2017 and available online at https://federalregister.gov/d/2017-24517, and on FDsys.gov DEPARTMENT OF COMMERCE International Trade Administration Initiation of Antidumping and Countervailing Duty Administrative Reviews AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce SUMMARY: The Department of Commerce (the Department) has received requests to conduct administrative reviews of various antidumping and countervailing duty orders and findings with September anniversary dates. In accordance with the Department’s regulations, we are initiating those administrative reviews. DATES: Applicable [Insert date of publication in the Federal Register]. FOR FURTHER INFORMATION CONTACT: Brenda E. Waters, Office of AD/CVD Operations, Customs Liaison Unit, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue, NW, Washington, DC 20230, telephone: (202) 482-4735. SUPPLEMENTARY INFORMATION: Background The Department has received timely requests, in accordance with 19 CFR 351.213(b), for administrative reviews of various antidumping and countervailing duty orders and findings with September anniversary dates. All deadlines for the submission of various types of information, certifications, or comments or actions by the Department discussed below refer to the number of calendar days from the applicable starting time. 2 Notice of No Sales If a producer or exporter named in this notice of initiation had no exports, sales, or entries during the period of review (POR), it must notify the Department within 30 days of publication of this notice in the Federal Register. All submissions must be filed electronically at http://access.trade.gov in accordance with 19 CFR 351.303.1 Such submissions are subject to verification in accordance with section 782(i) of the Tariff Act of 1930, as amended (the Act). -
Issn 2229-4104 Asia Pacific Journal of Research
APJRBM Volume 3, Issue 1 (January, 2012) ISSN 2229-4104 The Journal of Sri Krishna Research & Educational Consortium ASIA PACIFIC JOURNAL OF RESEARCH IN BUSINESS MANAGEMENT Internationally Indexed & Listed Referred e-Journal APPLICATION OF Z SCORE ANALYSIS IN EVALUATING STEEL INDUSTRY IN INDIA DR. KAVITA CHAVALI*; MS. KARTHIKA.S** *Associate Professor, Alliance University, Bangalore – 562106. **Research Associate, Alliance University, Bangalore – 562106. ABSTRACT The paper is an empirical study to understand the financial soundness of steel industry in India. For this purpose twenty large and medium steel units which are listed are taken. A sample period of 2001 - 2010 was selected for the study. The financial performance of the Steel industry was monitored and measured by using Altman’s Z-score model which was extensively used by practitioners and researchers in the past. This study analyses the possibility of business failure with reasonable accuracy by using the z-score model. The research findings are that the steel industry is in good financial performance inspite of the impact of sluggish demand and global economic slowdown with an exception of two companies in the study period. KEYWORDS: Steel Industry, Z score, Bankruptcy, Financial Soundness. ______________________________________________________________________________ INTRODUCTION Companies exist for making profits and to create value to the share holder. It is very important for bankers, researchers, regulatory agencies to predict the bankruptcy to lessen the impact of it. If a company goes bankrupt / fail the shareholders of the company and also the public at large get affected. The impact is much more if it is a manufacturing industry like Steel. “Failure” is defined as the inability of a firm to pay its financial obligations as they mature (Beaver, 1966). -
Page # 1 / 7 Ador Welding Limited
ADOR WELDING LIMITED LIST OF SHAREHOLDERS WHOSE SHARES ARE LIABLE TO BE TRANSFERRED TO INVESTOR EDUCATION AND PROTECTION FUND (IEPF) AUTHORITY IN FY 2020-21 DUE DATE OF SRNO DPID LF CLTID HOLD NAME ADD1 ADD2 ADD3 ADD4 TRANSFER DELHI 1 A14457 90 ANIL AKASH BAJAJ FLAT NO 24 LEHNA SINGH MARKET 110007 29-Sep-20 DELHI 2 K12707 150 KASTURI LAL BHAMBRI B 49 GUJRANWALA TOWN DELHI 110009 29-Sep-20 NEW DELHI 3 K14417 7 KANTA THAKRAL B-129 MALVIYA NAGAR 110017 29-Sep-20 NEW DELHI 4 M12752 75 M S DAVAR A-4/7 KONARK APARTMENTS KALKAJI EXTNS 110019 29-Sep-20 NEW DELHI 5 R02241 150 RAMESH SANGTANI C/O MR DEWAN SANGTANI A-1/70,LAJPAT NAGAR, 110024 29-Sep-20 NEW DELHI 6 O12031 125 OM PRAKASH KHANNA ROAD NO 25 H NO 16 F FLOOR EAST PUNJABI BAGH 110026 29-Sep-20 NEW DELHI 7 V12087 247 VIMLESH KUMAR MEHROTRA TYPE II/41 B T P S STAFF COLONY BADARPUR,NEW DELHI 110044 29-Sep-20 DELHI 8 K14401 75 KANTA CHAUDHARY BK-18 SHALIMAR BAGH (W) DELHI 110052 29-Sep-20 NEW DELHI 9 V12866 150 VIMAL CHETAL 4-A, MOUNT KAILASH NEW DELHI 110065 29-Sep-20 HARYANA 10 V13416 75 VINAY MALIK 306/27, OPPOSITE 129-L MODEL TOWN ROHATAK 121001 29-Sep-20 LUDHIANA 11 G12450 247 GURMEET SINGH C/O NGP ENGINEERS G T ROAD HILLERGANJ 141003 29-Sep-20 LUDHIANA 12 K12419 247 KESAR KAUR 229-C MODEL TOWN EXTENSION 141003 29-Sep-20 AMRITSAR 13 R02248 150 RAMESH KUMAR GANDHI 63A RANI KA BAGH NEAR GOVT COLLEGE FOR WOMEN PUNJAB 143001 29-Sep-20 JALANDHAR CITY 14 S17345 22 SANJEEV KUMAR M/S LAKSHMI DIESELS MANDI ROAD 144001 29-Sep-20 NOIDA 15 T12665 100 TRIPTA VERMA D-23 SECTOR-15 201301 29-Sep-20 KANPUR